Newstral
Bristol Myers Squibb
- FDA Approves BMS and J&J CAR-T Cell Therapies for the Earlier Treatment of Multiple Myelomajdsupra.com
- PTed Danson Has the Sweetest Advice for a Long-Lasting Marriageparade.com
- Sen. Wicker must stop Bernie’s push towards socialized medicineoxfordeagle.com
- CSenators grilled Big Pharma CEOs Joaquin Duato, Robert Davis, and Chris Boerner on Drug Pricingceoworld.biz
- M&A Designed For A Low-Growth WorldForbes
- CAurora Cannabis Bolsters Leadership with Pharmaceutical Veteran Simona King as CFOceoworld.biz
- This $674 Million Deal Aims To Turn Your Body's Garbage Disposal Into A Disease FighterForbes
- Big Pharma spends billions more on executives and stockholders than on R&DArs Technica
- Senate panel grills pharmaceutical company execs over prescription drug pricesUSA today
- TDrug price negotiations, legal battles set to ramp up: What to expectthehill.com
- MMerck, J&J CEOs comply with testify in Senate listening to on drug costsmvtelegraph.com
- Merck, Johnson & Johnson CEOs agree to appear before Senate health panelrollcall.com
- Scientists Will Test a Cancer-Hunting mRNA TreatmentWired.com
- BOzempic mania fuels deal optimism across drug industrybloomberg.com
- MGSK to buy asthma drug developer for up to $1.4 billion in pipeline push3 min readmarketwatch.com
- DAmbrx Biopharma soars on $2 billion takeover by Johnson & Johnsondcourier.com
- Where To Invest In 2024 - Value Is UndervaluedForbes
- DRayzeBio soars; Bristol Myers to pay $4.1 billion in second major buy in 3 daysdcourier.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.